Commentary on Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic re

星级：  1 页

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer

星级：  10 页

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

星级：  6 页

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carc

星级：  8 页

A Phase II Study of Erlotinib and Bevacizumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and N

星级：  23 页

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carc

星级：  13 页

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma A G

星级：  1 页

A Phase II Study of Oxaliplatin, Dose-intense Capecitabine, and High-dose Bevacizumab in the Treatment of Metastatic Colorectal

星级：  7 页